Skip to main content
OpenTrials

Clinical trial condition

Demyelinating Diseases

Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.

2,934 public trials 459 recruiting studies
Refine in advanced search Browse all conditions

Demyelinating Diseases trial results

Completed

Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis

NCT03593590

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Landesklinikum Amstetten Amstetten, Austria
  • Uniklinik fuer Neurologie, Medizinische Universitaet Innsbruck Innsbruck, Austria
  • Kepler Universitätsklinikum GmbH - Neuromed Campus Linz, Austria
  • Kepler Universitätskliniken GmbH - Med Campus III Linz, Austria
View all 158 locations
View Trial Details
Completed

Prospective Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) After Initiation and During Treatment With Ocrelizumab

NCT04377555

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +9 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Keck School of Medicine of USC Los Angeles, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Baptist Neurology - Beaches Jacksonville Beach, Florida, United States
View all 28 locations
View Trial Details
Completed

Oral Cladribine B-cell Study

NCT06415864

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
Locations
  • Barts Health NHS Trust London, United Kingdom
View Trial Details

Related conditions